Global Antineoplastic Agents Sales Market Report to 2021

November 2016 | 103 pages | ID: G2B39AEAF53EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Antineoplastic Agents

Revenue, means the sales value of Antineoplastic Agents

This report studies sales (consumption) of Antineoplastic Agents in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Antineoplastic Agents in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Alkylating Agent
• Anti-metabolic Tumor Drugs
• Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
• Others

Split by applications, this report focuses on sales, market share and growth rate of Antineoplastic Agents in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

Global Antineoplastic Agents Sales Market Report 2021

1 ANTINEOPLASTIC AGENTS OVERVIEW

1.1 Product Overview and Scope of Antineoplastic Agents
1.2 Classification of Antineoplastic Agents
  1.2.1 Alkylating Agent
  1.2.2 Anti-metabolic Tumor Drugs
  1.2.3 Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives
  1.2.4 Others
1.3 Applications of Antineoplastic Agents
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Antineoplastic Agents Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Antineoplastic Agents (2011-2021)
  1.5.1 Global Antineoplastic Agents Sales, Revenue and Price (2011-2021)
  1.5.2 Global Antineoplastic Agents Sales and Growth Rate (2011-2021)
  1.5.3 Global Antineoplastic Agents Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTINEOPLASTIC AGENTS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Antineoplastic Agents Market Competition by Manufacturers
  2.1.1 Global Antineoplastic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Antineoplastic Agents Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Antineoplastic Agents (Volume and Value) by Type
  2.2.1 Global Antineoplastic Agents Sales and Market Share by Type (2011-2021)
  2.2.2 Global Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
2.3 Global Antineoplastic Agents (Volume and Value) by Regions
  2.3.1 Global Antineoplastic Agents Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Antineoplastic Agents Revenue and Market Share by Regions (2011-2021)
2.4 Global Antineoplastic Agents (Volume) by Application

3 NORTH AMERICA ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

3.1 North America Antineoplastic Agents Sales and Value (2011-2021)
  3.1.1 North America Antineoplastic Agents Sales and Growth Rate (2011-2021)
  3.1.2 North America Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  3.1.3 North America Antineoplastic Agents Sales Price Trend (2011-2021)
3.2 North America Antineoplastic Agents Sales and Market Share by Manufacturers
3.3 North America Antineoplastic Agents Sales and Market Share by Type
3.4 North America Antineoplastic Agents Sales and Market Share by Applications

4 CHINA ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

4.1 China Antineoplastic Agents Sales and Value (2011-2021)
  4.1.1 China Antineoplastic Agents Sales and Growth Rate (2011-2021)
  4.1.2 China Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  4.1.3 China Antineoplastic Agents Sales Price Trend (2011-2021)
4.2 China Antineoplastic Agents Sales and Market Share by Manufacturers
4.3 China Antineoplastic Agents Sales and Market Share by Type
4.4 China Antineoplastic Agents Sales and Market Share by Applications

5 EUROPE ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

5.1 Europe Antineoplastic Agents Sales and Value (2011-2021)
  5.1.1 Europe Antineoplastic Agents Sales and Growth Rate (2011-2021)
  5.1.2 Europe Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Antineoplastic Agents Sales Price Trend (2011-2021)
5.2 Europe Antineoplastic Agents Sales and Market Share by Manufacturers
5.3 Europe Antineoplastic Agents Sales and Market Share by Type
5.4 Europe Antineoplastic Agents Sales and Market Share by Applications

6 JAPAN ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

6.1 Japan Antineoplastic Agents Sales and Value (2011-2021)
  6.1.1 Japan Antineoplastic Agents Sales and Growth Rate (2011-2021)
  6.1.2 Japan Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Antineoplastic Agents Sales Price Trend (2011-2021)
6.2 Japan Antineoplastic Agents Sales and Market Share by Manufacturers
6.3 Japan Antineoplastic Agents Sales and Market Share by Type
6.4 Japan Antineoplastic Agents Sales and Market Share by Applications

7 SOUTHEAST ASIA ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Antineoplastic Agents Sales and Value (2011-2021)
  7.1.1 Southeast Asia Antineoplastic Agents Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Antineoplastic Agents Sales Price Trend (2011-2021)
7.2 Southeast Asia Antineoplastic Agents Sales and Market Share by Manufacturers
7.3 Southeast Asia Antineoplastic Agents Sales and Market Share by Type
7.4 Southeast Asia Antineoplastic Agents Sales and Market Share by Applications

8 INDIA ANTINEOPLASTIC AGENTS (VOLUME, VALUE AND SALES PRICE

8.1 India Antineoplastic Agents Sales and Value (2011-2021)
  8.1.1 India Antineoplastic Agents Sales and Growth Rate (2011-2021)
  8.1.2 India Antineoplastic Agents Revenue and Growth Rate (2011-2021)
  8.1.3 India Antineoplastic Agents Sales Price Trend (2011-2021)
8.2 India Antineoplastic Agents Sales and Market Share by Manufacturers
8.3 India Antineoplastic Agents Sales and Market Share by Type
8.4 India Antineoplastic Agents Sales and Market Share by Applications

9 GLOBAL ANTINEOPLASTIC AGENTS MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Antineoplastic Agents Product Type and Technology
    9.1.2.1 Alkylating Agent
    9.1.2.2 Anti-metabolic Tumor Drugs
  9.1.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Antineoplastic Agents Product Type and Technology
    9.2.2.1 Alkylating Agent
    9.2.2.2 Anti-metabolic Tumor Drugs
  9.2.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Antineoplastic Agents Product Type and Technology
    9.3.2.1 Alkylating Agent
    9.3.2.2 Anti-metabolic Tumor Drugs
  9.3.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Antineoplastic Agents Product Type and Technology
    9.4.2.1 Alkylating Agent
    9.4.2.2 Anti-metabolic Tumor Drugs
  9.4.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Antineoplastic Agents Product Type and Technology
    9.5.2.1 Alkylating Agent
    9.5.2.2 Anti-metabolic Tumor Drugs
  9.5.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Antineoplastic Agents Product Type and Technology
    9.6.2.1 Alkylating Agent
    9.6.2.2 Anti-metabolic Tumor Drugs
  9.6.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Antineoplastic Agents Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2017)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Antineoplastic Agents Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Antineoplastic Agents Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Abbvie
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Antineoplastic Agents Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Antineoplastic Agents Sales, Revenue, Price of Company One (2015 and 2021)
9.11 AMGen
9.12 Teva Pharmaceutical Industries Ltd.
9.13 Bayer AG
9.14 Bristol-Myers Squibb
9.15 Astellas Pharma
9.16 Daiichi Sankyo

10 ANTINEOPLASTIC AGENTS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Antineoplastic Agents Technology Analysis
10.2 Antineoplastic Agents Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antineoplastic Agents
Table Classification of Antineoplastic Agents
Figure Global Sales Market Share of Antineoplastic Agents by Type in 2015
Figure Alkylating Agent Picture
Figure Anti-metabolic Tumor Drugs Picture
Figure Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives Picture
Figure Others Picture
Table Applications of Antineoplastic Agents
Figure Global Sales Market Share of Antineoplastic Agents by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure North America Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure China Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Europe Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Japan Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure India Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table Global Antineoplastic Agents Sales, Revenue and Price (2011-2021)
Figure Global Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Global Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Table Global Antineoplastic Agents Sales of Key Manufacturers (2015 and 2016)
Table Global Antineoplastic Agents Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antineoplastic Agents Sales Share by Manufacturers
Figure 2016 Antineoplastic Agents Sales Share by Manufacturers
Table Global Antineoplastic Agents Revenue by Manufacturers (2015 and 2016)
Table Global Antineoplastic Agents Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Antineoplastic Agents Revenue Share by Manufacturers
Table 2016 Global Antineoplastic Agents Revenue Share by Manufacturers
Table Global Antineoplastic Agents Sales and Market Share by Type (2011-2021)
Table Global Antineoplastic Agents Sales Share by Type (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Type (2011-2021)
Figure Global Antineoplastic Agents Sales Growth Rate by Type (2011-2021)
Table Global Antineoplastic Agents Revenue and Market Share by Type (2011-2021)
Table Global Antineoplastic Agents Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Type (2011-2021)
Figure Global Antineoplastic Agents Revenue Growth Rate by Type (2011-2021)
Table Global Antineoplastic Agents Sales and Market Share by Regions (2011-2021)
Table Global Antineoplastic Agents Sales Share by Regions (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Regions (2011-2021)
Figure Global Antineoplastic Agents Sales Growth Rate by Regions (2011-2021)
Table Global Antineoplastic Agents Revenue and Market Share by Regions (2011-2021)
Table Global Antineoplastic Agents Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Antineoplastic Agents by Regions (2011-2021)
Figure Global Antineoplastic Agents Revenue Growth Rate by Regions (2011-2021)
Table Global Antineoplastic Agents Sales and Market Share by Application (2011-2021)
Table Global Antineoplastic Agents Sales Share by Application (2011-2021)
Figure Sales Market Share of Antineoplastic Agents by Application (2011-2021)
Figure Global Antineoplastic Agents Sales Growth Rate by Application (2011-2021)
Figure North America Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure North America Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure North America Antineoplastic Agents Sales Price Trend (2011-2021)
Table North America Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table North America Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table North America Antineoplastic Agents Sales by Type (2015 and 2016)
Table North America Antineoplastic Agents Market Share by Type (2015 and 2016)
Table North America Antineoplastic Agents Sales by Applications (2015 and 2016)
Table North America Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Europe Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Europe Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Europe Antineoplastic Agents Sales Price Trend (2011-2021)
Table Europe Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Europe Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Europe Antineoplastic Agents Sales by Type (2015 and 2016)
Table Europe Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Europe Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Europe Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure China Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure China Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure China Antineoplastic Agents Sales Price Trend (2011-2021)
Table China Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table China Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table China Antineoplastic Agents Sales by Type (2015 and 2016)
Table China Antineoplastic Agents Market Share by Type (2015 and 2016)
Table China Antineoplastic Agents Sales by Applications (2015 and 2016)
Table China Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Japan Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Japan Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Japan Antineoplastic Agents Sales Price Trend (2011-2021)
Table Japan Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Japan Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Japan Antineoplastic Agents Sales by Type (2015 and 2016)
Table Japan Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Japan Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Japan Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure India Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure India Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure India Antineoplastic Agents Sales Price Trend (2011-2021)
Table India Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table India Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table India Antineoplastic Agents Sales by Type (2015 and 2016)
Table India Antineoplastic Agents Market Share by Type (2015 and 2016)
Table India Antineoplastic Agents Sales by Applications (2015 and 2016)
Table India Antineoplastic Agents Market Share by Applications (2015 and 2016)
Figure Southeast Asia Antineoplastic Agents Sales and Growth Rate (2011-2021)
Figure Southeast Asia Antineoplastic Agents Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Antineoplastic Agents Sales Price Trend (2011-2021)
Table Southeast Asia Antineoplastic Agents Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Antineoplastic Agents Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Antineoplastic Agents Sales by Type (2015 and 2016)
Table Southeast Asia Antineoplastic Agents Market Share by Type (2015 and 2016)
Table Southeast Asia Antineoplastic Agents Sales by Applications (2015 and 2016)
Table Southeast Asia Antineoplastic Agents Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Antineoplastic Agents Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)